|
|
|
||
(State or other jurisdiction of incorporation or organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
The
|
Large accelerated filer
|
☐ |
Accelerated filer
|
☐ |
|
☒ |
Smaller reporting company
|
|
Emerging growth company
|
|
|
Page
|
|
|
|
1
|
||
|
|
|
Item 1.
|
1
|
|
|
|
|
|
1
|
|
|
|
|
|
2
|
|
|
|
|
|
3
|
|
|
|
|
|
4
|
|
|
|
|
|
5
|
|
|
|
|
Item 2.
|
25
|
|
|
|
|
Item 3.
|
30 | |
|
|
|
Item 4.
|
30 | |
|
|
|
31
|
||
|
|
|
Item 1.
|
31 | |
|
|
|
Item 1A.
|
31 | |
|
|
|
Item 2.
|
31
|
|
|
|
|
Item 3.
|
31
|
|
|
|
|
Item 4.
|
31 | |
|
|
|
Item 5.
|
31 | |
|
|
|
Item 6.
|
32
|
|
|
|
|
35 |
September 30,
|
December 31,
|
|||||||
2024
(Unaudited) |
2023 | |||||||
Assets:
|
||||||||
Current assets:
|
||||||||
Cash
|
$
|
|
$
|
|
||||
Restricted cash
|
||||||||
Income tax receivable
|
||||||||
Prepaid expenses
|
|
|
||||||
Total current asset
|
|
|
||||||
Cash held in Trust Account
|
|
|
||||||
Total assets
|
$
|
|
$
|
|
||||
|
||||||||
Liabilities and Stockholders’ Deficit
|
||||||||
Current liabilities:
|
||||||||
Accounts payable and accrued expenses
|
$
|
|
$
|
|
||||
Franchise taxes payable | ||||||||
Excise tax payable |
||||||||
Redemption payable |
||||||||
Total current liabilities
|
|
|
||||||
Warrant liability
|
|
|
||||||
Marketing agreement |
||||||||
Total liabilities
|
|
|
||||||
|
||||||||
Commitments and Contingencies (Note 6)
|
||||||||
Class A common stock subject to possible redemption,
|
|
|
||||||
|
||||||||
Stockholders’ Deficit:
|
||||||||
Preferred stock, $
|
|
|
||||||
Class A common stock, $
|
|
|
||||||
Class B common stock, $
|
|
|
||||||
Additional paid-in capital
|
|
|
||||||
Accumulated deficit
|
(
|
)
|
(
|
)
|
||||
Total stockholders’ deficit
|
(
|
)
|
(
|
)
|
||||
Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Deficit
|
$
|
|
$
|
|
For the Three Months Ended
September 30,
|
For the Nine Months
Ended
September 30,
|
|||||||||||||||
2024
|
2023
|
2024
|
2023
|
|||||||||||||
Operating costs
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Loss from operations
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Other Income, net
|
||||||||||||||||
Change in fair value of warrant liabilities
|
|
(
|
)
|
(
|
)
|
(
|
)
|
|||||||||
Recovery of offering costs allocated to warrants |
||||||||||||||||
Operating account interest income
|
|
|
|
|
||||||||||||
Income from Trust Account
|
|
|
|
|
||||||||||||
Total other income, net
|
|
|
|
|
||||||||||||
(Loss) income before provision for income taxes
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|||||||||
Provision for income taxes
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption
|
|
|
|
|
||||||||||||
Basic and diluted net loss per share, Class A common stock subject to possible redemption
|
$ | ( |
) | $ | ( |
) | $ | ( |
) | $ | ( |
) | ||||
Basic and diluted weighted average shares outstanding, non-redeemable Class A and Class B common stock
|
|
|
|
|
||||||||||||
Basic and diluted net loss per share, non-redeemable Class A and Class B common stock
|
$
|
(
|
)
|
$
|
(
|
)
|
$ | ( |
) | $ | ( |
) |
Class A Common Stock |
Class B Common Stock
|
|||||||||||||||||||||||||||
Shares | Amount |
Shares
|
Amount
|
Additional
Paid-in Capital
|
Accumulated
Deficit
|
Stockholders’
Deficit
|
||||||||||||||||||||||
Balance as of January 1, 2024
|
$ |
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||||||||
Net loss
|
— |
—
|
|
|
(
|
)
|
(
|
)
|
||||||||||||||||||||
Remeasurement of Class A
common stock subject to
possible redemption to
redemption amount
|
— | — | ( |
) | ( |
) | ||||||||||||||||||||||
Balance as of March 31, 2024
|
$ |
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
||||||||||||||||
Net loss
|
— |
— | ( |
) | ( |
) | ||||||||||||||||||||||
Remeasurement of Class A
common stock subject to
possible redemption to
redemption amount
|
— |
— | ( |
) | ( |
) | ||||||||||||||||||||||
Balance as of June 30, 2024
|
$ | $ | $ | $ | ( |
) | $ | ( |
) | |||||||||||||||||||
Net loss | — |
— | ( |
) | ( |
) | ||||||||||||||||||||||
Remeasurement of Class A common stock subject to possible redemption to redemption amount
|
— |
— | ( |
) | ( |
) | ||||||||||||||||||||||
Balance as of September 30, 2024 |
$ |
|
$ |
$ |
$ |
( |
) | $ |
( |
) |
Class B Common Stock
|
||||||||||||||||||||
Shares
|
Amount
|
Additional
Paid-in Capital
|
Accumulated
Deficit
|
Stockholders’
Deficit
|
||||||||||||||||
Balance as of January 1, 2023
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
|||||||||
Net income
|
—
|
|
|
|
|
|||||||||||||||
Accretion for Class A common stock to redemption amount |
— |
( |
) | ( |
) | |||||||||||||||
Balance as of March 31, 2023
|
|
|
|
(
|
)
|
(
|
)
|
|||||||||||||
Excise tax payable in connection with redemptions
|
— |
( |
) | ( |
) | |||||||||||||||
Net loss |
— |
( |
) | ( |
) | |||||||||||||||
Extension funding of Trust Account |
( |
) | ( |
) | ||||||||||||||||
Remeasurement adjustment of carrying value of Class A common stock to redemption amount
|
— |
( |
) | ( |
) | |||||||||||||||
Balance as of June 30, 2023 | $ | $ | $ | ( |
) | $ | ( |
) | ||||||||||||
Waiver of Deferred Underwriters’ Fee |
— |
|||||||||||||||||||
Net loss |
— | ( |
) | ( |
) | |||||||||||||||
Extension funding of Trust Account |
— | ( |
) | ( |
) | |||||||||||||||
Remeasurement adjustment of carrying value of Class A common stock to redemption amount
|
— |
( |
) | ( |
) | |||||||||||||||
Balance as of September 30, 2023 |
$ | $ | $ | ( |
) | $ | ( |
) |
For the Nine Months Ended
September 30,
|
||||||||
|
2024
|
2023
|
||||||
Cash flows from operating activities:
|
||||||||
Net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Adjustments to reconcile net loss to net cash used in operating activities:
|
||||||||
Change in fair value of warrant liability
|
|
|
||||||
Recovery of offering
costs allocated to warrants
|
( |
) | ||||||
Income from investments held in Trust Account
|
(
|
)
|
(
|
)
|
||||
Changes in assets and liabilities:
|
||||||||
Prepaid expenses
|
(
|
)
|
|
|||||
Accounts payable and accrued expenses
|
|
|
||||||
Franchise tax payable
|
(
|
)
|
(
|
)
|
||||
Due to related party
|
|
|
||||||
Income taxes payable
|
(
|
)
|
(
|
)
|
||||
Net cash used in operating activities
|
(
|
)
|
(
|
)
|
||||
|
||||||||
Cash flows from investing activities:
|
||||||||
Trust extension funding
|
( |
) | ||||||
Investments in trust account
|
( |
) | ||||||
Cash withdrawn from Trust Account in connection with redemption
|
||||||||
Cash withdrawn from Trust Account to pay taxes obligation
|
||||||||
Return of excess withdrawals for taxes
|
( |
) | ||||||
Net cash provided by investing activities
|
||||||||
Cash flows from financing activities:
|
||||||||
Redemption of common stock
|
( |
) | ( |
) | ||||
Proceeds from issuance of promissory note to related party
|
||||||||
Net cash used in financing activities
|
( |
) | ( |
) | ||||
Net change in cash
|
(
|
)
|
(
|
)
|
||||
Cash, beginning of the period
|
|
|
||||||
Cash, end of the period
|
$
|
|
$
|
|
||||
|
||||||||
Supplemental disclosure of cash flow information:
|
||||||||
Accretion for Class A common stock to redemption amount |
$
|
|
$
|
|
||||
Excise tax payable in connection with redemption
|
$
|
|
$
|
|
||||
Impact of the waiver of deferred commission by the underwriters | $ | $ |
For the Three Months Ended September 30,
|
||||||||||||||||
2024 |
2023 |
|||||||||||||||
Redeemable
Class A
|
Non-redeemable
Class A and Class
B
|
Redeemable
Class A
|
Non-redeemable
Class A and Class
B
|
|||||||||||||
Basic diluted net loss per share
|
||||||||||||||||
Numerator:
|
||||||||||||||||
Allocation of net loss
|
$
|
(
|
)
|
$
|
(
|
)
|
$ | ( |
) |
$
|
(
|
)
|
||||
Denominator:
|
||||||||||||||||
Weighted average shares outstanding
|
|
|
|
|||||||||||||
Basic and diluted net loss per share
|
$
|
(
|
)
|
$
|
(
|
)
|
$ | ( |
) | $ | ( |
) |
For the Nine Months Ended September 30,
|
||||||||||||||||
2024
|
2023
|
|||||||||||||||
Redeemable
Class A
|
Non-redeemable
Class A and Class
B
|
Redeemable
Class A
|
Non-redeemable
Class A and Class
B
|
|||||||||||||
Basic diluted net loss per share
|
||||||||||||||||
Numerator:
|
||||||||||||||||
Allocation of net (loss) income
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
||||
Denominator:
|
||||||||||||||||
Weighted average shares outstanding
|
|
|
|
|
||||||||||||
Basic and diluted net loss per share
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$ | ( |
) |
September 30,
2024
|
December 31,
2023
|
|||||||
As of beginning of the period
|
$
|
|
$
|
|
||||
Less: |
||||||||
Redemptions
|
( |
) | ||||||
Plus:
|
||||||||
Extension funding of Trust Account
|
||||||||
Remeasurement adjustment of carrying value to redemption value
|
|
|
||||||
Class A common stock subject to possible redemption
|
$
|
|
$
|
|
• |
in whole and not in part;
|
• |
at a price of $
|
• |
upon a minimum of
|
• |
if, and only if, the closing price of the Class A common stock equals or exceeds $
|
• |
in whole and not in part;
|
• |
at $
|
• |
if, and only if, the closing price of the Company’s Class A common stock equals or exceeds $
|
• |
if the closing price of the Class A common stock for any
|
|
September 30, 2024 | |||||||||||
Level 1 |
Level 2 |
Level 3 |
||||||||||
Public Warrants
|
$
|
|
$
|
|
$
|
|
||||||
Private Warrants
|
$
|
|
$
|
|
$
|
|
||||||
Working Capital Loan Conversion Option | $ | $ | $ |
|
December 31, 2023 |
|||||||||||
Level 1 |
Level 2 |
Level 3 |
||||||||||
Public Warrants
|
$
|
|
$
|
|
$
|
|
||||||
Private Warrants
|
$
|
|
$
|
|
$
|
|
||||||
Working Capital Loan Conversion Option | $ |
$ | $ |
Input
|
September 30, 2024
|
December 31, 2023
|
||||||
Risk-free interest rate
|
|
%
|
|
%
|
||||
Expected term to Initial Business Combination (years)
|
|
|
||||||
Expected volatility
|
de minimis
|
%
|
de minimis
|
|
||||
Common stock price
|
$
|
|
$
|
|
||||
Dividend yield
|
|
%
|
|
%
|
December 31, 2023
|
$
|
|
||
|
|
|||
March 31, 2024 | $ | |||
( |
) | |||
June 30, 2024 | $ | |||
|
( |
) | ||
September 30, 2024
|
$ | |||
December 31, 2022 | $ | |||
March 31, 2023 | $ | |||
June 30, 2023 | $ | |||
|
||||
September 30, 2023
|
$ |
•
|
the adjustment to the warrant price of the Warrants from $
|
•
|
the adjustment of the $
|
•
|
the adjustment of the $
|
•
|
pursuant to Section 4.2 of the Warrant Agreement, as a result of the
consummation of the Business Combination, each Warrant will be exercisable for
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk.
|
Item 4. |
Controls and Procedures.
|
Item 1. |
Legal Proceedings
|
Item 1A. |
Risk Factors
|
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds.
|
Item 3. |
Defaults Upon Senior Securities
|
Item 4. |
Mine Safety Disclosures.
|
Item 5. |
Other Information.
|
Item 6. |
Exhibits
|
Exhibit
Number
|
Description
|
|
|
2.1†
|
|
2.2
|
|
2.3
|
|
2.4
|
|
3.1
|
|
3.2
|
|
4.1
|
|
4.2
|
|
4.3
|
|
10.1
|
|
10.2
|
|
10.3
|
|
10.4+
|
|
10.5
|
10.6
|
|
10.7
|
|
10.8
|
|
10.9
|
|
10.10
|
|
10.11
|
|
10.12
|
|
10.13
|
|
10.14
|
|
10.15
|
|
10.16
|
|
10.17+
|
|
10.18+
|
|
10.19+
|
|
10.20
|
|
10.21
|
|
10.22 |
|
21.1
|
|
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
101.INS*
|
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
|
101.SCH*
|
Inline XBRL Taxonomy Extension Schema Document
|
101.DEF*
|
Inline XBRL Taxonomy Extension Definition Linkbase Document
|
101.LAB*
|
Inline XBRL Taxonomy Extension Labels Linkbase Document
|
101.PRE*
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document
|
104*
|
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
|
*
|
Filed herewith.
|
**
|
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
|
†
|
Schedules and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.
|
+
|
Indicates management contract or compensatory plan.
|
DEVVSTREAM CORP. (F.K.A. FOCUS IMPACT ACQUISITION CORP.)
|
||
/s/ David Goertz
|
||
Name:
|
David Goertz
|
|
Title:
|
Chief Financial Officer
|
|
(Principal Financial and Accounting Officer)
|